Overview
Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. It is made in India by Ranbaxy Labs and sold under the trade name Volix.
Background
Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. It is made in India by Ranbaxy Labs and sold under the trade name Volix.
Indication
For the treatment of diabetes. It is specifically used for lowering post-prandial blood glucose levels thereby reducing the risk of macrovascular complications.
Associated Conditions
- Hyperglycemia, Postprandial
- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2023/01/18 | Phase 3 | Not yet recruiting | |||
2014/11/10 | Phase 4 | Completed | |||
2014/03/27 | Phase 4 | UNKNOWN | Post Graduate Institute of Medical Education and Research, Chandigarh | ||
2014/01/30 | Phase 4 | Completed | |||
2013/11/25 | N/A | Completed | |||
2011/03/07 | Phase 4 | Completed | |||
2010/12/20 | Phase 2 | Completed | |||
2010/12/20 | Phase 2 | Completed | |||
2010/12/20 | Phase 2 | Completed | |||
2009/09/02 | Phase 4 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Voglibose Chewable Tablets | 国药准字H20090313 | 化学药品 | 片剂 | 11/24/2023 | |
Voglibose Chewable Tablets | 国药准字H20090045 | 化学药品 | 片剂 | 8/4/2023 | |
Voglibose Chewable Tablets | 国药准字H20100076 | 化学药品 | 片剂 | 2/28/2020 | |
Voglibose Chewable Tablets | 国药准字H20090301 | 化学药品 | 片剂 | 2/6/2024 | |
Voglibose Tablets | 国药准字H20213711 | 化学药品 | 片剂 | 9/13/2021 | |
Voglibose Tablets | 国药准字H20103217 | 化学药品 | 片剂 | 2/21/2020 | |
Voglibose Tablets | 国药准字H20103291 | 化学药品 | 片剂 | 4/8/2020 | |
Voglibose Tablets | 国药准字H20233588 | 化学药品 | 片剂 | 5/19/2023 | |
Voglibose Tablets | 国药准字H20094209 | 化学药品 | 片剂 | 6/12/2024 | |
Voglibose Tablets | 国药准字H20183479 | 化学药品 | 片剂 | 11/16/2023 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |